Growth Metrics

Incyte (INCY) EBT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -313.33%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 71.54%
7 Evaxion A 64.16 Bn 64.14 Bn - -79.57%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 9,460.35%
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 46.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 46.72%
Dec 31, 2025 24.29%
Sep 30, 2025 208.14%
Jun 30, 2025 243.16%
Mar 31, 2025 -0.83%
Dec 31, 2024 15.78%
Sep 30, 2024 -33.05%
Jun 30, 2024 -240.41%
Mar 31, 2024 355.41%
Dec 31, 2023 236.11%
Sep 30, 2023 57.35%
Jun 30, 2023 21.02%
Mar 31, 2023 -26.48%
Dec 31, 2022 -32.83%
Sep 30, 2022 -29.06%
Jun 30, 2022 33.64%
Mar 31, 2022 1.75%
Dec 31, 2021 -28.60%
Sep 30, 2021 6,071.18%
Jun 30, 2021 -44.14%
Mar 31, 2021 109.85%
Dec 31, 2020 33.41%
Sep 30, 2020 -102.37%
Jun 30, 2020 182.75%
Mar 31, 2020 -776.37%
Dec 31, 2019 78.18%
Sep 30, 2019 377.85%
Jun 30, 2019 101.21%
Mar 31, 2019 357.96%
Dec 31, 2018 147.69%
Sep 30, 2018 -28.55%
Jun 30, 2018 675.53%
Mar 31, 2018 79.62%
Dec 31, 2017 -1,669.90%
Sep 30, 2017 13.19%
Jun 30, 2017 -126.65%
Mar 31, 2017 -909.85%
Dec 31, 2016 -83.04%
Sep 30, 2016 196.79%
Jun 30, 2016 273.38%
Mar 31, 2016 235.88%
Dec 31, 2015 249.70%
Sep 30, 2015 -166.66%
Jun 30, 2015 125.62%
Mar 31, 2015 46.94%
Dec 31, 2014 12.95%
Sep 30, 2014 369.99%
Jun 30, 2014 -1,372.12%
Mar 31, 2014 -117.00%
Dec 31, 2013 -326.59%
Sep 30, 2013 -1.40%
Jun 30, 2013 -160.92%
Mar 31, 2013 65.60%
Dec 31, 2012 134.24%
Sep 30, 2012 59.15%
Jun 30, 2012 107.91%
Mar 31, 2012 -71.34%
Dec 31, 2011 -269.26%
Sep 30, 2011 -64.03%
Jun 30, 2011 -1,636.89%
Mar 31, 2011 25.11%